Pseudotumor cerebri epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Pseudotumor cerebri}} {{CMG}}; {{AE}} ==Overview== ==Epidemiology and Demographics== ===Incidence=== *The incidence/prevalence of [disease name] is approximatel...")
 
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 7: Line 7:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
The [[incidence]] of Pseudotumor cerebri is approximately 1 to 2 per 100,000 population annualy.<ref name="pmid3395261">{{cite journal |vauthors=Durcan FJ, Corbett JJ, Wall M |title=The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana |journal=Arch. Neurol. |volume=45 |issue=8 |pages=875–7 |date=August 1988 |pmid=3395261 |doi= |url=}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.


===Prevalence===
=== Prevalence ===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
The [[prevalence]] of Pseudotumor cerebri is approximately 5.1 per 100 000 in the general population in a Spanish study[17raood 2011] and 10.9 per 100 000 in american study. This higher [[prevalence]] may reflect the UK increased proportion of [[Obesity|obese]] individuals.<ref name="pmid21426442">{{cite journal |vauthors=Raoof N, Sharrack B, Pepper IM, Hickman SJ |title=The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK |journal=Eur. J. Neurol. |volume=18 |issue=10 |pages=1266–8 |date=October 2011 |pmid=21426442 |doi=10.1111/j.1468-1331.2011.03372.x |url=}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Age and gender===
Most of the [[Idiopathic intracranial hypertension|IIH]] cases happen in women in child bearing age<ref name="pmid1998880">{{cite journal |vauthors=Wall M, George D |title=Idiopathic intracranial hypertension. A prospective study of 50 patients |journal=Brain |volume=114 ( Pt 1A) |issue= |pages=155–80 |date=February 1991 |pmid=1998880 |doi= |url=}}</ref>, but it can also happens in children and old adult with male gender. In prepubertal age the gender is not an important [[risk factor]] and in old patients the percent of affected males was higher than females.<ref name="pmid9534686">{{cite journal |vauthors=Soler D, Cox T, Bullock P, Calver DM, Robinson RO |title=Diagnosis and management of benign intracranial hypertension |journal=Arch. Dis. Child. |volume=78 |issue=1 |pages=89–94 |date=January 1998 |pmid=9534686 |pmc=1717437 |doi= |url=}}</ref><ref name="pmid11937898">{{cite journal |vauthors=Bandyopadhyay S, Jacobson DM |title=Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria |journal=J Neuroophthalmol |volume=22 |issue=1 |pages=9–11 |date=March 2002 |pmid=11937898 |doi= |url=}}</ref>
===Race===
===Race===
*There is no racial predilection to [disease name].
Black patients may have more severe [[outcome]] than other population.<ref name="pmid15337617">{{cite journal |vauthors=Galvin JA, Van Stavern GP |title=Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center |journal=J. Neurol. Sci. |volume=223 |issue=2 |pages=157–60 |date=August 2004 |pmid=15337617 |doi=10.1016/j.jns.2004.05.009 |url=}}</ref>
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Latest revision as of 16:05, 8 August 2018

Pseudotumor cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pseudotumor cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudotumor cerebri epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudotumor cerebri epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudotumor cerebri epidemiology and demographics

CDC on Pseudotumor cerebri epidemiology and demographics

Pseudotumor cerebri epidemiology and demographics in the news

Blogs on Pseudotumor cerebri epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pseudotumor cerebri epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and Demographics

Incidence

The incidence of Pseudotumor cerebri is approximately 1 to 2 per 100,000 population annualy.[1]

Prevalence

The prevalence of Pseudotumor cerebri is approximately 5.1 per 100 000 in the general population in a Spanish study[17raood 2011] and 10.9 per 100 000 in american study. This higher prevalence may reflect the UK increased proportion of obese individuals.[2]

Age and gender

Most of the IIH cases happen in women in child bearing age[3], but it can also happens in children and old adult with male gender. In prepubertal age the gender is not an important risk factor and in old patients the percent of affected males was higher than females.[4][5]

Race

Black patients may have more severe outcome than other population.[6]

References

  1. Durcan FJ, Corbett JJ, Wall M (August 1988). "The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana". Arch. Neurol. 45 (8): 875–7. PMID 3395261.
  2. Raoof N, Sharrack B, Pepper IM, Hickman SJ (October 2011). "The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK". Eur. J. Neurol. 18 (10): 1266–8. doi:10.1111/j.1468-1331.2011.03372.x. PMID 21426442.
  3. Wall M, George D (February 1991). "Idiopathic intracranial hypertension. A prospective study of 50 patients". Brain. 114 ( Pt 1A): 155–80. PMID 1998880.
  4. Soler D, Cox T, Bullock P, Calver DM, Robinson RO (January 1998). "Diagnosis and management of benign intracranial hypertension". Arch. Dis. Child. 78 (1): 89–94. PMC 1717437. PMID 9534686.
  5. Bandyopadhyay S, Jacobson DM (March 2002). "Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria". J Neuroophthalmol. 22 (1): 9–11. PMID 11937898.
  6. Galvin JA, Van Stavern GP (August 2004). "Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center". J. Neurol. Sci. 223 (2): 157–60. doi:10.1016/j.jns.2004.05.009. PMID 15337617.

Template:WH Template:WS